Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Altered Angiogenic Gene Expression Profiles in Porcine Von Willebrand Disease

Mario von Depka, MD PhD, Katharina Kaiser, Carsten Detering, MSc, Mahnaz Ekhlasi-Hundrieser, PhD, Christiane Pfarrer, DVM, Prof, Stefanie Lehner, DVM, PhD

Blood (2019) 134 (Supplement_1): 4917.

https://doi.org/10.1182/blood-2019-122407

Published: 2019

Journal Articles

Expression Profile of VEGF and VEGFR2 in the Female Reproductive Tract at the Time of Placentation in a Porcine Model of Von Willebrand Disease Type 1

Mario von Depka, MD PhD, Mahnaz Ekhlasi-Hundrieser, Carsten Detering, MSc, Stefanie Lehner, Christiane Pfarrer, Hanna Allerkamp

Blood (2018) 132 (Supplement 1): 3776.

https://doi.org/10.1182/blood-2018-99-112085

Published: 2018

Journal Articles

Immunohistochemical Analyses and Quantitative RT-PCR of Angiogenic Factors in a Porcine Von Willebrand Disease Model

Mario Von Depka, MD PhD, Hanna Allerkamp, Mahnaz Ekhlasi-Hundrieser, Christiane Pfarrer, Carsten Detering, MSc, Stefanie Lehner

Blood (2017) 130 (Supplement 1): 1074.

https://doi.org/10.1182/blood.V130.Suppl_1.1074.1074

Published: 2017

Journal Articles

Management of Perioperative Anticoagulation in Patients with VWD

Mario Von Depka, MD PhD, Carsten Detering, MSc, Stefanie Döpke, Mahnaz Ekhlasi-Hundrieser, PhD

Blood (2015) 126 (23): 1100.

https://doi.org/10.1182/blood.V126.23.1100.1100

Published: 2015

Journal Articles

Management Of Pregnancy In Patients With Antithrombin Deficiency

Mario von Depka, MD PhD, Stefanie Döpke, Anja Henkel-Klene, MD, Cornelia Wermes, MD, Mahnaz Ekhlasi-Hundrieser, PhD, Carsten Detering

Blood (2013) 122 (21): 216.

https://doi.org/10.1182/blood.V122.21.216.216

Published: 2013

Journal Articles

Safety and Efficacy of Prophylactic Intravenous Administration of Recombinant Human Antithrombin (rhAT) to Hereditary AT Deficient Patients in High-Risk Situations.

Mario von Depka, MD, PhD, Don Shaffer, MD, Francesco Baudo, MD, Caroline Shiach, MD, Johan Frieling, MD, PhD, Judith Bonfiglio, BSN, CRNA, the GTC rHAT Study Group

Blood (2004) 104 (11): 4076.

https://doi.org/10.1182/blood.V104.11.4076.4076

Published: 2004

NARROW

Altered Angiogenic Gene Expression Profiles in Porcine Von Willebrand Disease

Expression Profile of VEGF and VEGFR2 in the Female Reproductive Tract at the Time of Placentation in a Porcine Model of Von Willebrand Disease Type 1

Immunohistochemical Analyses and Quantitative RT-PCR of Angiogenic Factors in a Porcine Von Willebrand Disease Model

Management of Perioperative Anticoagulation in Patients with VWD

Management Of Pregnancy In Patients With Antithrombin Deficiency

Safety and Efficacy of Prophylactic Intravenous Administration of Recombinant Human Antithrombin (rhAT) to Hereditary AT Deficient Patients in High-Risk Situations.

Email alerts

ASH Publications

American Society of Hematology

Altered Angiogenic Gene Expression Profiles in Porcine Von Willebrand Disease

Expression Profile of VEGF and VEGFR2 in the Female Reproductive Tract at the Time of Placentation in a Porcine Model of Von Willebrand Disease Type 1

Immunohistochemical Analyses and Quantitative RT-PCR of Angiogenic Factors in a Porcine Von Willebrand Disease Model

Management of Perioperative Anticoagulation in Patients with VWD

Management Of Pregnancy In Patients With Antithrombin Deficiency

Safety and Efficacy of Prophylactic Intravenous Administration of Recombinant Human Antithrombin (rhAT) to Hereditary AT Deficient Patients in High-Risk Situations.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only